TrialBritish journal of clinical pharmacology2023

A single-centre, open-label, single-arm, fixed-sequence pharmacokinetic study of SHR3680 on repaglinide and bupropion in prostate cancer patients.

Tao Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.